Vedolizumab for stricturing Crohn’s disease of the terminal ileum – an international multicenter cohort study

Abstract Objective Crohn’s disease (CD) frequently progresses to stricturing complications. Anti-stricture therapies are lacking, and anti-inflammatory therapies are hence the mainstay of medical treatment. However, data on the efficacy of vedolizumab in stricturing CD are not available. We therefor...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Sara El Ouali, Mark E. Baker, Cathy Lu, Alexandra Medellin, David H. Bruining, Joel G. Fletcher, Akitoshi Inoue, Miguel Regueiro, Ronald K. Ottichilo, Shayla Schoenoff, Ryan Rosentreter, James Bena, Taha Qazi, Stefan D. Holubar, Samantha Gauriloff, Namita S. Gandhi, Katherine Falloon, Joseph Sleiman, Benjamin L. Cohen, Idan Goren, Numan Balci, Florian Rieder, the Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2026-05-01
Schriftenreihe:	BMC Gastroenterology
Schlagworte:	Crohn’s disease Surgery Dilation Stricture Intervention Vedolizumab
Online-Zugang:	https://doi.org/10.1186/s12876-026-04815-4
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!